Skip to: Content
Skip to: Site Navigation
Skip to: Search
SUNDAY, NOVEMBER 22, 2009
| Subscribe to Newser's RSS feeds RSS | Follow Newser on Twitter Twitter

NEWS ABOUT: olaparib

olaparib stories: 2 news summaries
OPINION

 New Class of Drugs Could 
 Revolutionize Cancer Treatment 


PARP inhibitors show potential to transform understanding of cancer

Jun 25, 09 9:12 AM CDT
(Newser) - A new class of drugs in development represents the biggest cancer breakthrough in a decade, Robert Bazell writes at NBC. In a study causing much excitement in the medical world, breast, ovarian, and prostate cancer patients treated with Olaparib, one of a group of drugs known as PARP inhibitors, had... More »

MORE ABOUT:
breast cancer • ovarian cancer • cancer treatment • cancer drug • olaparib • PARP inhibitors • women's issues

Drug Offers Hope for Genetic Breast Cancer Sufferers

First-of-its-kind drug slows, stops tumor growth

Jun 1, 09 8:31 AM CDT
(Newser) - A first-of-its-kind drug has been developed to fight genetic breast cancer, with an initial round of human trials showing “very promising” results, reports the Times of London. The drug Olaparib works by blocking a protein that makes cancer cells containing the genetic default unable to repair themselves. The drug... More »

MORE ABOUT:
cancer • breast cancer • genetics • cancer research • cancer drug • olaparib

2 Stories


from our news partners